Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal ctDNA Monitoring in Older Women With ER+ Breast Cancer Who Forego Upfront Surgery in Favor of Primary Endocrine Therapy

NCT05914792 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT05914792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05914792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal ctDNA Monitoring in Older Women With ER+ Breast Cancer Who Forego Upfront Surgery in Favor of Primary Endocrine Therapy
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Active, not recruiting
Start date
April 19, 2022
Completion date
July 1, 2026
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer